Thus far, high-throughput resequencing efforts worldwide aimed at identifying unknown somatic mutations in human cancer have already revealed that yet uncharacterized mutations in KRAS, NRAS, BRAF, PIK3CA, PTEN and other cancer genes are highly prevalent45–47. The gene discussed is PIK3CA; the disease is cancer.